Hemp CBD: Even Without FDA Regulations, Class Action Suits May Go Forward
A couple of months ago we reported on a decision in the Southern District of Florida in which the court stayed a putative class action lawsuit against a seller of cannabidiol (CBD) products until the Food and Drug Administration (FDA) completes rulemaking regarding the marketing, including labeling, of hemp-derived ingestible products. The case is Snyder […]
Hemp CBD: Even Without FDA Regulations, Class Action Suits May Go Forward Read More »
